NASDAQ
Faron Pharmaceuticals Oy (FPHAF) has a free cash flow growth of -64.25% as of Friday, May 29, 2026. This represents a 92.07% increase compared to its 12-month average of -810.15%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.